SG Americas Securities’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,277
| Closed | -$14K | – | 2528 |
|
|
2025
Q1 | $14K | Sell |
22,277
-1,979
| -8% | -$1.24K | ﹤0.01% | 2968 |
|
|
2024
Q4 | $41K | Sell |
24,256
-3,138
| -11% | -$5.3K | ﹤0.01% | 2599 |
|
|
2024
Q3 | $50K | Buy |
27,394
+6,888
| +34% | +$12.6K | ﹤0.01% | 2867 |
|
|
2024
Q2 | $124K | Sell |
20,506
-3,400
| -14% | -$20.6K | ﹤0.01% | 2124 |
|
|
2024
Q1 | $267K | Sell |
23,906
-6,442
| -21% | -$71.9K | ﹤0.01% | 1564 |
|
|
2023
Q4 | $452K | Buy |
30,348
+20,279
| +201% | +$302K | ﹤0.01% | 1392 |
|
|
2023
Q3 | $48K | Buy |
+10,069
| New | +$48K | ﹤0.01% | 2647 |
|
|
2022
Q4 | – | Sell |
-50,536
| Closed | -$484K | – | 2691 |
|
|
2022
Q3 | $484K | Buy |
50,536
+1,815
| +4% | +$17.4K | 0.01% | 1388 |
|
|
2022
Q2 | $394K | Buy |
48,721
+13,595
| +39% | +$110K | ﹤0.01% | 1965 |
|
|
2022
Q1 | $594K | Buy |
35,126
+683
| +2% | +$11.6K | ﹤0.01% | 1582 |
|
|
2021
Q4 | $740K | Buy |
34,443
+24,445
| +244% | +$525K | ﹤0.01% | 1692 |
|
|
2021
Q3 | $738K | Buy |
9,998
+8,103
| +428% | +$598K | ﹤0.01% | 1992 |
|
|
2021
Q2 | $104K | Sell |
1,895
-1,361
| -42% | -$74.7K | ﹤0.01% | 2398 |
|
|
2021
Q1 | $240K | Buy |
+3,256
| New | +$240K | ﹤0.01% | 2320 |
|